Leerink Partners Downgrades Pliant Therapeutics (PLRX) to Market Perform, 'We await clarity on what that path forward would look like'
Tweet Send to a Friend
(Updated - March 3, 2025 1:08 PM EST)
Leerink Partners analyst Faisal A. Khurshid downgraded Pliant Therapeutics (NASDAQ: PLRX) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Leerink Partners analyst Faisal A. Khurshid downgraded Pliant Therapeutics (NASDAQ: PLRX) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
